source
- Johnson & Johnson to spend up to $750 million restructuring pharma manufacturing and closing plantsJohnson & Johnson announced it will incur up to $750 million as it reshapes its pharmaceutical manufacturing network. The plan involves exiting certain factories and consolidating production, aimi…
- Glenmark agrees to $29.6 million settlement over generic drug price-fixing claimsGlenmark Pharmaceuticals has reached a settlement with dozens of U.S. states, agreeing to pay $29.6 million to resolve accusations that it participated in a scheme to inflate prices of generic medi…